Insmed, Inc. (INSM)
121.16
+3.09
(+2.62%)
USD |
NASDAQ |
Nov 13, 16:00
121.00
-0.16
(-0.13%)
After-Hours: 06:53
Insmed Price : 121.16 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 118.18 | 121.54 | 116.97 | 121.16 | 1.544M |
| Nov 12, 2026 | 119.37 | 119.74 | 116.89 | 118.07 | 2.398M |
| Nov 11, 2026 | 119.49 | 120.88 | 117.26 | 120.75 | 1.489M |
| Nov 10, 2026 | 114.46 | 119.85 | 113.80 | 119.49 | 3.347M |
| Nov 09, 2026 | 114.82 | 116.36 | 112.61 | 116.10 | 2.669M |
| Nov 06, 2026 | 108.57 | 114.65 | 107.29 | 114.40 | 3.380M |
| Nov 05, 2026 | 109.40 | 109.98 | 106.16 | 108.76 | 2.616M |
| Nov 04, 2026 | 106.85 | 110.81 | 102.69 | 110.00 | 4.945M |
| Nov 03, 2026 | 109.31 | 111.11 | 104.25 | 104.44 | 6.216M |
| Nov 02, 2026 | 112.68 | 113.05 | 109.22 | 109.31 | 4.242M |
| Oct 30, 2026 | 113.60 | 116.37 | 111.97 | 112.58 | 5.185M |
| Oct 29, 2026 | 110.00 | 114.51 | 103.78 | 111.59 | 11.22M |
| Oct 28, 2026 | 94.01 | 97.92 | 93.86 | 96.98 | 4.649M |
| Oct 27, 2026 | 93.33 | 96.37 | 92.87 | 94.96 | 3.349M |
| Oct 26, 2026 | 93.44 | 94.34 | 92.96 | 93.33 | 3.380M |
| Oct 23, 2026 | 94.12 | 94.64 | 92.62 | 93.39 | 3.414M |
| Oct 22, 2026 | 93.50 | 95.59 | 93.33 | 95.06 | 3.100M |
| Oct 21, 2026 | 95.08 | 97.09 | 93.80 | 94.04 | 2.970M |
| Oct 20, 2026 | 95.44 | 97.20 | 94.60 | 95.67 | 2.613M |
| Oct 19, 2026 | 96.27 | 97.88 | 94.38 | 95.29 | 2.724M |
| Oct 16, 2026 | 98.70 | 99.00 | 96.05 | 96.27 | 2.397M |
| Oct 15, 2026 | 99.26 | 100.72 | 97.90 | 99.21 | 3.347M |
| Oct 14, 2026 | 97.39 | 98.00 | 95.76 | 97.79 | 2.737M |
| Oct 13, 2026 | 98.18 | 99.73 | 96.54 | 96.79 | 2.161M |
| Oct 12, 2026 | 98.82 | 100.31 | 98.33 | 98.56 | 1.696M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 165.04 |
| Gilead Sciences, Inc. | 168.08 |
| Incyte Corp. | 120.97 |
| Madrigal Pharmaceuticals, Inc. | 427.39 |
| Vertex Pharmaceuticals, Inc. | 538.60 |
Price Related Metrics
| PS Ratio | 17.25 |
| Price to Book Value | 36.59 |
| Earnings Yield | -2.32% |
| Market Cap | 26.57B |